Study of XL092 + Atezolizumab vs Regorafenib in Participants With Metastatic Colorectal Cancer
Clinical trial NCT05425940 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05425940
- Sponsor
- Exelixis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-07
- Primary completion
- 2026-06-16
- Enrollment
- 901
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.